XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation
 9 Months Ended
Oct. 29, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The stock-based compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended39-Weeks Ended
October 29,
2022		October 30,
2021		October 29,
2022		October 30,
2021
Stock-based compensation expense by type:
Stock options
$— $— $155 $174 
Restricted stock units1,269 1,126 4,881 4,005 
Employee stock purchases
69 47 304 156 
Director deferred compensation26 17 67 38 
  Total stock-based compensation expense1,364 1,190 5,407 4,373 
Income tax benefit recognized321 284 1,247 1,047 
  Stock-based compensation expense, net of income tax$1,043 $906 $4,160 $3,326 

Expense for restricted stock units is shown net of forfeitures which were immaterial for the 13-weeks and 39-weeks ended October 29, 2022 and October 30, 2021.
We granted the following equity awards:
13-Weeks Ended39-Weeks Ended
October 29,
2022		October 30,
2021		October 29,
2022		October 30,
2021
Stock options
— — 7,212 4,384 
Restricted stock unit awards
1,469 — 110,990 62,031 
Performance-based restricted stock unit awards
— — 49,978 22,492 
Deferred stock units
510 228 1,447 486 
At October 29, 2022, the total compensation cost not yet recognized related to unvested restricted stock unit awards was $8.8 million and the weighted-average period over which such awards are expected to be recognized was 1.9 years. There were no unrecognized compensation costs related to unvested stock options at October 29, 2022.

No stock options were granted during the 13-weeks ended October 29, 2022 or October 30, 2021. The weighted-average grant date fair value of stock options granted during the 39-weeks ended October 29, 2022 and October 30, 2021 was $21.46 and $39.73 per share, respectively.
Under the Hibbett, Inc. Amended and Restated Non-Employee Director Equity Plan, no shares of our common stock were awarded during the 13-weeks ended October 29, 2022 and 6,388 shares of our common stock were awarded during the 39-weeks ended October 29, 2022. No shares of our common stock were awarded during the 13-weeks or 39-weeks ended October 30, 2021.
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended39-Weeks Ended
October 29,
2022		October 30,
2021		October 29,
2022		October 30,
2021
Shares purchased6,408 2,495 28,033 12,003 
Average price per share$38.11 $65.11 $49.30 $47.95 
Weighted-average fair value at grant date$11.41 $22.22 $14.58 $13.68